Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

VALFLO PHARMA : revenue, balance sheet and financial ratios

VALFLO PHARMA is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ISBERGUES (62330), this company of category PME shows in 2017 a net income positive of 93 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - VALFLO PHARMA (SIREN 494413842)
Indicator 2017 2016
Revenue N/C N/C
Net income 93 263 € 6 360 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2017, VALFLO PHARMA generates positive net income of 93 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2017: 6 k€ -> 93 k€.

Net income (2017) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

93 263 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 205%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory.

Debt ratio (2017) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

204.954%

Financial autonomy (2017) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

32.741%

Solvency indicators evolution
VALFLO PHARMA

Sector positioning

Debt ratio
204.95 2017
2016
2017
Q1: 44.05
Med: 128.21
Q3: 288.79
Average -13 pts over 2 years

In 2017, the debt ratio of VALFLO PHARMA (204.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
32.74% 2017
2016
2017
Q1: 20.07%
Med: 35.54%
Q3: 55.67%
Average +11 pts over 2 years

In 2017, the financial autonomy of VALFLO PHARMA (32.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 5420.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2017) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

5420.603

Liquidity indicators evolution
VALFLO PHARMA

Sector positioning

Liquidity ratio
5420.6 2017
2016
2017
Q1: 115.53
Med: 157.08
Q3: 219.27
Excellent

In 2017, the liquidity ratio of VALFLO PHARMA (5420.60) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of VALFLO PHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 82 transactions of similar company sales in 2017, the value of VALFLO PHARMA is estimated at 1 058 712 € (range 766 799€ - 1 470 298€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2017
82 tx
766k€ 1058k€ 1470k€
1 058 712 € Range: 766 799€ - 1 470 298€
NAF 5 année 2017

Valuation method used

Net Income Multiple
93 263 € × 11.4x = 1 058 712 €
Range: 766 799€ - 1 470 298€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 82 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare VALFLO PHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about VALFLO PHARMA

What is the revenue of VALFLO PHARMA ?

The revenue of VALFLO PHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is VALFLO PHARMA profitable?

Yes, VALFLO PHARMA generated a net profit of 93 k€ in 2017.

Where is the headquarters of VALFLO PHARMA ?

The headquarters of VALFLO PHARMA is located in ISBERGUES (62330), in the department Pas-de-Calais.

Where to find the tax return of VALFLO PHARMA ?

The tax return of VALFLO PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does VALFLO PHARMA operate?

VALFLO PHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.